Impact Factor 2021 : 1.514 (@Clarivate Analytics)
5-Year Impact Factor: 2.699 (@Clarivate Analytics)
  • Users Online: 1493
  • Print this page
  • Email this page

    Article Cited by others


Pharmacodynamic profiling of optimal sulbactam regimens against carbapenem-resistant Acinetobacter baumannii for critically ill patients

Saelim Weerayuth, Santimaleeworagun Wichai, Thunyaharn Sudaluck, Changpradub Dhitiwat, Juntanawiwat Piraporn

Year : 2018| Volume: 8| Issue : 1 | Page no: 14-18

   This article has been cited by
1 Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature
Gowthami Sai Kogilathota Jagirdhar, Kaanthi Rama, Shiva Teja Reddy, Harsha Pattnaik, Rakhtan K. Qasba, Praveen Reddy Elmati, Rahul Kashyap, Marco Schito, Nitin Gupta
Antibiotics. 2023; 12(3): 582
[Pubmed]  [Google Scholar] [DOI]
2 Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
Weerayuth Saelim,Dhitiwat Changpradub,Sudaluck Thunyaharn,Piraporn Juntanawiwat,Parnrada Nulsopapon,Wichai Santimaleeworagun
Infection & Chemotherapy. 2021; 53(1): 128
[Pubmed]  [Google Scholar] [DOI]


Read this article